共 50 条
- [31] Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 936 - 943
- [32] 11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 921 - 929
- [36] EARLY AND LATE IMAGES OF 18F-CHOLINE (FCH) PET/CT FOR THE DETECTION OF PROSTATIC FOSSAE RECURRENCES IN PROSTATE CANCER WITH A BIOCHEMICAL FAILURE (PSA > 2 NG/ML) [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1030 - E1031
- [37] PET/CT with 18F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection? [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1418 - 1424
- [38] IS [11C]CHOLINE PET/CT RECOMMENDED FOR RESTAGING PROSTATE CANCER PATIENTS AFTER RADICAL PROSTATECTOMY WHEN PSA IS LOWER THAN 1 NG/ML? [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E78 - E79